Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

With Medicare Coverage Policy Pending, Blue Cross Finds Fault With ProDisc

This article was originally published in The Gray Sheet

Executive Summary

A recent negative assessment of lumbar artificial disc replacement by Blue Cross Blue Shield could spell trouble for Synthes as it seeks full Medicare coverage for ProDisc

You may also be interested in...



Long-Term Evidence On Artificial Cervical Discs Found Lacking By Blues' TEC

Long-term data is insufficient to show whether artificial intervertebral disc arthroplasty improves outcomes in the cervical spine, according to a recent assessment by the Blue Cross Blue Shield Association Technology Evaluation Center

Long-Term Evidence On Artificial Cervical Discs Found Lacking By Blues' TEC

Long-term data is insufficient to show whether artificial intervertebral disc arthroplasty improves outcomes in the cervical spine, according to a recent assessment by the Blue Cross Blue Shield Association Technology Evaluation Center

CMS Extends Non-Coverage Policy To All Artificial Lumbar Discs

CMS is proposing to extend its national non-coverage policy for Johnson & Johnson/DePuy's Charité to all current and future artificial lumbar discs

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024831

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel